MOUNTAIN VIEW, Calif., June 20, 2013 /PRNewswire/ -- Based on its recent analysis of the personalized cosmeceuticals market, Frost & Sullivan recognizes geneOnyx Limited with the 2013 European Frost & Sullivan Award for New Product Innovation. geneOnyx leverages a DNA testing platform originally used for medical point-of-care testing to create an on-the-spot genetic test for anti-aging cosmetics.
geneOnyx's test requires only a single-step DNA collection procedure from saliva to examine single nucleotide polymorphisms (SNPs)—or genetic variations—in key genes relating to important skin biochemical pathways. The sample is placed on a rapid lab-on-chip system, which is connected to a cloud-computing device linked to CosMos™, geneOnyx's patent-pending, cloud-based data analysis engine and ingredient library.
In 30 minutes, the system maps the personalized profile of the individual's genetic variations with compatible active ingredients and recommends a customized anti-aging serum that will be most effective for the individual. The DNA microchip will be securely disposed of immediately to ensure the confidentiality of the customer's profile.
"The DNA microchip is portable, resembling a USB memory stick, and enables testing outside the laboratory environment," said Frost & Sullivan Industry Analyst Vin Nee Lim. "geneOnyx DNA testing harnesses DNA Electronics' proprietary Genalysis® technology; geneOnyx™ obtained a worldwide exclusive license from DNA Electronics in 2012 for utilizing this technology in the cosmeceuticals sector."
The geneOnyx test is the first over-the-counter personalized genetic test. Dermatologists and cosmeticians find it highly useful in recommending skincare products with specific ingredients. As the test is user-friendly, they can easily be carried out by non-scientific trained personnel and conveniently performed in a ret
|SOURCE Frost & Sullivan|
Copyright©2012 PR Newswire.
All rights reserved